Tian-Liang Xia
Overview
Explore the profile of Tian-Liang Xia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
492
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Z, Xia T, Wang M, Zhang L, Liu Y, Yuan B, et al.
Med
. 2025 Jan;
100568.
PMID: 39793578
Background: The genomic landscape of esophageal squamous cell carcinoma (ESCC) has been characterized extensively, but there remains a significant need for actionable targets and effective therapies. Methods: Here, we perform...
2.
Zhu Q, Duan X, Hu H, You R, Xia T, Yu T, et al.
J Transl Med
. 2024 Dec;
22(1):1111.
PMID: 39695702
Cetuximab, an anti-epidermal growth factor receptor (EGFR) antibody, has been shown to improve survival in nasopharyngeal carcinoma (NPC) patients. However, a correlation between the expression of EGFR and the response...
3.
Dai D, Xie C, Zhong L, Liu S, Zhang L, Zhang H, et al.
Signal Transduct Target Ther
. 2024 Oct;
9(1):281.
PMID: 39384753
Axis inhibition protein 1 (AXIN1), a scaffold protein interacting with various critical molecules, plays a vital role in determining cell fate. However, its impact on the antiviral innate immune response...
4.
You R, Liu Y, Xie Y, Lin C, Duan C, Chen D, et al.
Lancet
. 2023 Feb;
401(10380):917-927.
PMID: 36842439
Background: Reirradiation in standard fractionation for locally advanced recurrent nasopharyngeal carcinoma after a previous course of high-dose radiotherapy is often associated with substantial late toxicity, negating its overall benefit. We...
5.
Fang S, Xia T, Fu J, Li T, Zhong Q, Han F
Technol Cancer Res Treat
. 2022 Nov;
21:15330338221139981.
PMID: 36412101
Nasopharyngeal carcinomas (NPCs) are malignant tumors originating from the lining epithelium of the nasopharynx. Fusion genes have been confirmed to play important roles in the occurrence and development of various...
6.
Wang X, Xia T, Tang H, Liu X, Han R, Zou X, et al.
Ann Transl Med
. 2022 Aug;
10(9):526.
PMID: 35928731
Background: Recurrent nasopharyngeal carcinoma (NPC) remains a major challenge for clinicians and scientists. Tumor organoid is a revelational disease model that highly resembled the heterogeneity and histopathological characteristics of original...
7.
Jin Y, Xia T, Mai D, Yao J, Jiang C, He W, et al.
BMC Cancer
. 2022 May;
22(1):505.
PMID: 35524225
Background: We aim to investigate the prognostic value of weight loss during radiotherapy (RT) among patients with nasopharyngeal carcinoma (NPC). Methods: A total of 1149 NPC patients who received radical...
8.
Dai D, Li X, Wang L, Xie C, Jin Y, Zeng M, et al.
J Biol Chem
. 2021 Sep;
297(4):101226.
PMID: 34571359
No abstract available.
9.
Chen Z, Yan S, Chen X, Zhang Q, Liu S, Liu Y, et al.
Genome Med
. 2021 Sep;
13(1):146.
PMID: 34493320
Background: Epstein-Barr virus (EBV)-associated gastric carcinomas (EBVaGCs) present unique molecular signatures, but the tumorigenesis of EBVaGCs and the role EBV plays during this process remain poorly understood. Methods: We applied...
10.
Dai D, Li X, Wang L, Xie C, Jin Y, Zeng M, et al.
J Biol Chem
. 2021 Mar;
296:100547.
PMID: 33741341
N6-methyladenosine (mA) is among the most abundant mRNA modifications, particularly in eukaryotes, and is found in mammals, plants, and even some viruses. Although essential for the regulation of many biological...